The role of tumour–stromal interactions in modifying drug response: challenges and opportunities

DW McMillin, JM Negri, CS Mitsiades - Nature reviews Drug discovery, 2013 - nature.com
The role of stromal cells and the tumour microenvironment in general in modulating tumour
sensitivity is increasingly becoming a key consideration for the development of active …

The multiple uses of fluorescent proteins to visualize cancer in vivo

RM Hoffman - Nature Reviews Cancer, 2005 - nature.com
Naturally fluorescent proteins have revolutionized biology by enabling what was formerly
invisible to be seen clearly. These proteins have allowed us to visualize, in real time …

Human breast cancer cells educate macrophages toward the M2 activation status

S Sousa, R Brion, M Lintunen, P Kronqvist… - Breast cancer …, 2015 - Springer
Introduction The immune system plays a major role in cancer progression. In solid tumors, 5-
40% of the tumor mass consists of tumor-associated macrophages (TAMs) and there is …

Regulation of cancer cell migration and bone metastasis by RANKL

DH Jones, T Nakashima, OH Sanchez, I Kozieradzki… - Nature, 2006 - nature.com
Bone metastases are a frequent complication of many cancers that result in severe disease
burden and pain,,. Since the late nineteenth century, it has been thought that the …

Bisphosphonates Inhibit Angiogenesis in Vitro and Testosterone-stimulated Vascular Regrowth in the Ventral Prostate in Castrated Rats

P Fournier, S Boissier, S Filleur, J Guglielmi, F Cabon… - Cancer research, 2002 - AACR
Bisphosphonates (BPs) are used currently in the treatment of patients with bone metastases
because these compounds inhibit bone resorption. We examined here the effects of BPs on …

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

A Boucharaba, CM Serre, S Grès… - The Journal of …, 2004 - Am Soc Clin Investig
The role of lysophosphatidic acid (LPA) in cancer is poorly understood. Here we provide
evidence for a role of LPA in the progression of breast cancer bone metastases. LPA …

Bisphosphonates: preclinical review

JR Green - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the mechanism of action of first-generation and nitrogen-containing …

Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

F Pantano, M Croset, K Driouch, N Bednarz-Knoll… - Oncogene, 2021 - nature.com
Bone metastasis remains a major cause of mortality and morbidity in breast cancer.
Therefore, there is an urgent need to better select high-risk patients in order to adapt …

Antitumor effects of bisphosphonates

JR Green - Cancer: Interdisciplinary International Journal of the …, 2003 - Wiley Online Library
BACKGROUND Bisphosphonates are widely used to treat skeletal complications of
malignancy. These drugs accumulate in bone where they inhibit osteoclastic bone …

Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone

R Leblanc, SC Lee, M David, JC Bordet… - Blood, The Journal …, 2014 - ashpublications.org
Autotaxin (ATX), through its lysophospholipase D activity controls physiological levels of
lysophosphatidic acid (LPA) in blood. ATX is overexpressed in multiple types of cancers …